This independent HPLC-MS lab test confirms Retatrutide 20mg from Orbitrex Peptides at 99.96% purity. The analysis was conducted by Freedom Diagnostics on January 8, 2026.
Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist researched for its potential role in metabolic regulation, weight management, and glycemic control. A purity level of 99.96% indicates minimal contamination and high-grade synthesis.
Endotoxin testing passed at ≤ 0.05 EU/mL across both replicates, demonstrating safety standards for research applications. The full certificate of analysis is available for download on this page.

Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.